When AI Sees Liver Disease Before Doctors

Artificial intelligence is demonstrating capabilities beyond human expertise in detecting life-threatening liver diseases affecting millions globally. This session presents groundbreaking research showing 87.9% sensitivity in detecting early-stage cholangiocarcinoma compared to radiologists' 50%, revealing how deep learning and topological data analysis identify disease patterns invisible to human observation. Attendees will learn about real-world implementation results, including AI's ability to predict hepatic decompensation 1.5 years before clinical manifestation, enabling earlier intervention and optimized transplant timing. The session provides evidence-based insights into how advanced analytical techniques can transform diagnostic accuracy and clinical outcomes in hepatology, with potential implications for early disease detection across other clinical specialties.